2-羟基-4-甲基苯甲腈 | 18495-14-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 2-羟基-4-甲基苯甲腈
• 中文别名: 2-羟基-4-甲基苯腈
• 英文名称: 2-hydroxy-4-methylbenzonitrile
• CAS: 18495-14-2
• 化学式: C₈H₇NO
• 分子量: 133.15
• InChiKey: WAFLXCCXXVMUKI-UHFFFAOYSA-N

物化性质

• 熔点：
  87 °C
• 沸点：
  286.0±28.0 °C(Predicted)
• 密度：
  1.17±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  44
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2926909090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Hydroxy-4-methylbenzonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Hydroxy-4-methylbenzonitrile
CAS number: 18495-14-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H7NO
Molecular weight: 133.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-羟基-4-甲基苯甲腈 在 potassium carbonate 、 potassium hydroxide 、 叔丁醇 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 5.5h， 生成 2-甲氧基-4-甲基-苯甲酸酰胺
  参考文献：
  名称：

  路易斯酸促进酚的位点选择性氰化。

  摘要：

  已经开发出有效的路易斯酸促进的3-取代的和3，4-二取代的苯酚的位点选择性亲电子氰化。使用MeSCN作为氰化试剂的氰化反应可以高效地进行，从而以高效率和出色的区域选择性提供了广泛的2-羟基苄腈。该协议可以为合成和修饰生物活性分子提供实用的方法。

  DOI：

  10.1039/d0ob00737d
• 作为产物：
  描述：

  2-羟基-4-甲基苯甲醛肟 在 偶氮二甲酸二异丙酯 、 三苯基膦 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 2-羟基-4-甲基苯甲腈
  参考文献：
  名称：

  钴/Salox 催化的对映选择性脱氢 C-H 烷氧基化和胺化

  摘要：

  报道了前所未有的对映选择性脱氢 C-H 烷氧基化和胺化。使用廉价且易于获得的钴 (II) 盐作为催化剂和 Salox 作为手性配体提供了一种有效的方法来获得具有优异对映选择性（高达 >99 % ee）的 P-立体化合物。

  DOI：

  10.1002/anie.202210106
• 作为试剂：
  描述：

  三氯化硼 、 间甲酚 、 硫氰酸甲酯 、 三氯化铝 在 2-羟基-4-甲基苯甲腈 、 resultant mixture 、 sodium hydroxide 、 二氯甲烷 、 乙醚 、 magnesium sulfate 、 crude material 、 silica gel 、 ethyl acetate dichloromethane 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 3.75h， 以provided 1.16 g (91%) of 2-Hydroxy-4-methylbenzonitrile as a white solid的产率得到2-羟基-4-甲基苯甲腈
  参考文献：
  名称：

  Chemokine receptor binding heterocyclic compounds

  摘要：

  本发明揭示了调节趋化因子受体活性的化合物。这些化合物通常为包含四氢喹啉和苯并咪唑的三级胺。

  公开号：

  US20030028022A1

文献信息

• [EN] COMPOUNDS AND METHODS<br/>[FR] COMPOSÉS ET MÉTHODES
  申请人：TEMPERO PHARMACEUTICALS INC

  公开号：WO2013019682A1

  公开（公告）日：2013-02-07

  The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORy.

  本发明涉及新型视黄醛酸相关孤儿受体γ（RORγ）调节剂及其在治疗由RORγ介导的疾病中的应用。
• Identification of Adenosine Deaminase Inhibitors by Metal‐binding Pharmacophore Screening
  作者：Rebecca N. Adamek、Paul Ludford、Stephanie M. Duggan、Yitzhak Tor、Seth M. Cohen

  DOI：10.1002/cmdc.202000271

  日期：2020.11.18

  more rapid drug discovery efforts for this target, an in vitro assay was developed that utilizes the enzymatic conversion of a visibly emitting adenosine analogue to the corresponding fluorescent inosine analogue by ADA, which can be monitored via fluorescence intensity changes. Utilizing this assay, a library of ∼350 small molecules containing metal‐binding pharmacophores (MBPs) was screened in an HTS

  腺苷脱氨酶 (ADA) 是一种人类单核 Zn 2+将腺苷转化为肌苷的金属酶。ADA 是一种经过验证的癌症药物靶点，但最近在开发针对这种酶的新疗法方面的工作很少。缺乏新进展的部分原因是缺乏针对 ADA 的高通量筛选 (HTS) 的合适检测方法。为了促进针对该目标的更快速的药物发现工作，开发了一种体外测定法，该测定法利用 ADA 将可见发射的腺苷类似物酶促转化为相应的荧光肌苷类似物，这可以通过荧光强度变化进行监测。利用该测定，以 HTS 格式筛选了一个包含 350 个包含金属结合药效团 (MBP) 的小分子的文库，以鉴定针对 ADA 的新抑制剂支架。K i值为 26±1 μM。
• [EN] HETEROCYCLIC DERIVATIVES AS RORGAMMA MODULATORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES EN TANT QUE MODULATEURS RORGAMMA
  申请人：GENFIT

  公开号：WO2016102633A1

  公开（公告）日：2016-06-30

  The present invention provides novel compounds of formula (I) that are modulators of RORgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of RORgamma has therapeutic effects, for instance in autoimmune diseases, autoimmune-related diseases, inflammatory diseases, fibrotic diseases, or cholestatic diseases.

  本发明提供了一种新颖的公式(I)化合物，该化合物是RORgamma的调节剂。这些化合物以及包含相同化合物的药物组合物，适用于治疗任何一种疾病，其中调节RORgamma具有治疗作用，例如在自身免疫性疾病、自身免疫相关疾病、炎症性疾病、纤维化疾病或胆汁淤积性疾病中。
• Novel use of phenylheteroakylamine derivatives
  申请人：——

  公开号：US20030158185A1

  公开（公告）日：2003-08-21

  There is disclosed the use of a compound of formula (I) wherein R 1 , R 2 , X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts, enantiomers or racemates thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of nitric oxide synthase activity is beneficial. Certain novel compounds of formula (Ia) and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof are disclosed; together with processes for their preparation, compositions containing them and their use in therapy. The compounds of formulae (I) and (Ia) are inhibitors of the enzyme nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease.

  公开了使用式（I）的化合物，其中R1、R2、X、Y、V、W和Z如规范中定义，并且其药学上可接受的盐、对映体或消旋体，在制备药物时用于治疗或预防抑制一氧化氮合酶活性有益的疾病或症状。公开了式（Ia）的某些新化合物及其药学上可接受的盐，以及其对映体和消旋体；以及它们的制备方法、含有它们的组合物以及它们在治疗中的应用。式（I）和（Ia）的化合物是一氧化氮合酶酶的抑制剂，因此在治疗或预防炎症性疾病方面特别有用。
• Facile One-Pot Transformation of Phenols into<i>o</i>-Cyanophenols
  作者：Yuhta Nakai、Katsuhiko Moriyama、Hideo Togo

  DOI：10.1002/ejoc.201402817

  日期：2014.9

  The treatment of phenols with paraformaldehyde in the presence of MgCl2 and Et3N in THF at 80 °C, followed by reaction with molecular iodine and aq. ammonia at room temperature provided the corresponding o-cyanophenols in moderate to good yields. The present reaction is a one-pot transformation of phenols into o-cyanophenols using much less expensive reagents than are typically used; the reaction is

  在 MgCl2 和 Et3N 的四氢呋喃中，在 80 °C 下用多聚甲醛处理苯酚，然后与分子碘和水溶液反应。氨在室温下以中等至良好的产率提供相应的邻氰基酚。本反应是使用比通常使用的试剂便宜得多的试剂将苯酚一锅法转化为邻氰基苯酚；该反应不含过渡金属和氰化物。在我们从对溴苯酚制备非布司他的过程中强调了该反应的效用。